• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; GORE® EXCLUDER® AAA ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; GORE® EXCLUDER® AAA ENDOPROSTHESIS Back to Search Results
Model Number RMT281412
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 11/22/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), users are made aware of the risks associated with type ii endoleaks and are instructed to consider the risks and benefits discussed in the ifu for each patient before using the devices.Additionally, per ifu, adverse events that may occur and / or require intervention include, but are not limited to endoleak and aneurysm enlargement.
 
Event or Problem Description
It was reported that the patient presented on (b)(6) 2014, with a 51 mm abdominal aortic aneurysm that was treated with gore® excluder® aaa endoprostheses.Follow-up imaging showed that the aneurysm size appeared to be stable until minor aneurysm growth was visible on (b)(6) 2016 (52 mm).On (b)(6) 2017, a type ii endoleak originating from the inferior mesenteric artery was identified and unsuccessfully treated with embolization on an unknown date.Aneurysm growth to 60 mm was visible on (b)(6) 2017.On (b)(6) 2019, the endoleak was treated with the implantation of an additional aortic endograft.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Common Device Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10360825
Report Number3007284313-2020-01019
Device Sequence Number16386853
Product Code MIH
UDI-Device Identifier00733132610709
UDI-Public00733132610709
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source health professional,study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/31/2016
Device Model NumberRMT281412
Device Catalogue NumberRMT281412
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/07/2020
Supplement Date Received by Manufacturer07/07/2020
Initial Report FDA Received Date08/04/2020
Supplement Report FDA Received Date01/13/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
Yes
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient Weight73
-
-